Results
1199
Companies which are more than 50% undervalued based on analyst price target.
1,199 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSTR | US$318.67 | -2.5% | 373.6% | US$85.9b | US$513.01 | PS177x | E57.1% | n/a | Software | ||
FSLR | US$162.50 | 2.5% | 8.3% | US$17.4b | US$268.19 | PE13.9x | E24.5% | n/a | Semiconductors | ||
SMMT | US$21.60 | 10.4% | 425.5% | US$15.5b | US$33.08 | PB36.4x | E38.9% | n/a | Pharmaceuticals & Biotech | ||
WST | US$202.49 | -37.2% | -43.2% | US$15.3b | US$305.75 | PE29.8x | E8.0% | 0.4% | Pharmaceuticals & Biotech | ||
MRNA | US$35.90 | 17.6% | -59.0% | US$13.8b | US$57.32 | PS4.3x | E30.3% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$83.36 | -2.4% | 15.4% | US$10.3b | US$149.89 | PB3x | E29.3% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$107.12 | -2.4% | -19.0% | US$10.1b | US$181.78 | PE84x | E30.1% | n/a | Pharmaceuticals & Biotech | ||
VFS | US$3.83 | 2.1% | -27.2% | US$9.0b | US$6.33 | PS6.1x | E1.0% | n/a | Automobiles | ||
PSN | US$65.08 | -14.3% | -13.6% | US$7.8b | US$112.01 | PE29.4x | E19.7% | n/a | Commercial Services | ||
RVMD | US$42.34 | 0.8% | 45.1% | US$7.7b | US$73.29 | PS10544.8x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
CACI | US$344.51 | -3.2% | -6.0% | US$7.6b | US$520.83 | PE16.1x | E8.1% | n/a | Commercial Services | ||
AES | US$10.40 | 3.1% | -37.2% | US$7.3b | US$15.85 | PE7.2x | E12.5% | 6.8% | Utilities | ||
LEGN | US$38.75 | 8.0% | -35.2% | US$7.0b | US$79.50 | PS13.7x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
BILL | US$57.95 | -5.1% | -5.5% | US$6.1b | US$88.40 | PE72.2x | E-8.3% | n/a | Software | ||
ZETA | US$23.08 | 8.3% | 129.7% | US$5.9b | US$36.92 | PS6.1x | E125.6% | n/a | Software | ||
LNTH | US$81.39 | -0.9% | 43.5% | US$5.8b | US$133.46 | PE13.2x | E12.8% | n/a | Healthcare | ||
ELAN | US$11.24 | -1.2% | -30.4% | US$5.6b | US$16.92 | PE27.1x | E1.6% | n/a | Pharmaceuticals & Biotech | ||
ANF | US$105.11 | -3.5% | -10.4% | US$5.5b | US$187.40 | PE9.9x | E4.9% | 0% | Retail | ||
MARA | US$15.78 | -2.8% | -31.1% | US$5.4b | US$26.92 | PE32.5x | E-35.8% | n/a | Software | ||
CYTK | US$46.40 | 10.0% | -39.3% | US$5.4b | US$79.55 | PS1701.1x | E39.3% | n/a | Pharmaceuticals & Biotech | ||
IONS | US$31.81 | 3.1% | -26.9% | US$5.0b | US$61.32 | PS7.1x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
COTY | US$5.53 | -2.6% | -56.3% | US$4.9b | US$8.68 | PE16073.7x | E73.3% | 0% | Household | ||
MOD | US$88.92 | -8.8% | 14.7% | US$4.9b | US$147.35 | PE29.2x | E30.1% | n/a | Automobiles | ||
CRSP | US$53.02 | 22.4% | -35.7% | US$4.5b | US$83.60 | PS121.9x | E47.8% | n/a | Pharmaceuticals & Biotech |